Rabbit Recombinant Monoclonal TNFRSF14/HVEM antibody. Suitable for ICC, IHC-P, WB and reacts with Human samples. Immunogen corresponding to Recombinant Fragment Protein within Human TNFRSF14 aa 1-200.
pH: 7.8 - 8.6
Preservative: 0.09% Sodium azide
Constituents: 98% Borate buffered saline
ICC | IHC-P | WB | |
---|---|---|---|
Human | Tested | Tested | Tested |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Receptor for four distinct ligands: The TNF superfamily members TNFSF14/LIGHT and homotrimeric LTA/lymphotoxin-alpha and the immunoglobulin superfamily members BTLA and CD160, altogether defining a complex stimulatory and inhibitory signaling network (PubMed:10754304, PubMed:18193050, PubMed:23761635, PubMed:9462508). Signals via the TRAF2-TRAF3 E3 ligase pathway to promote immune cell survival and differentiation (PubMed:19915044, PubMed:9153189, PubMed:9162022). Participates in bidirectional cell-cell contact signaling between antigen presenting cells and lymphocytes. In response to ligation of TNFSF14/LIGHT, delivers costimulatory signals to T cells, promoting cell proliferation and effector functions (PubMed:10754304). Interacts with CD160 on NK cells, enhancing IFNG production and anti-tumor immune response (PubMed:23761635). In the context of bacterial infection, acts as a signaling receptor on epithelial cells for CD160 from intraepithelial lymphocytes, triggering the production of antimicrobial proteins and pro-inflammatory cytokines (By similarity). Upon binding to CD160 on activated CD4+ T cells, down-regulates CD28 costimulatory signaling, restricting memory and alloantigen-specific immune response (PubMed:18193050). May interact in cis (on the same cell) or in trans (on other cells) with BTLA (By similarity) (PubMed:19915044). In cis interactions, appears to play an immune regulatory role inhibiting in trans interactions in naive T cells to maintain a resting state. In trans interactions, can predominate during adaptive immune response to provide survival signals to effector T cells (By similarity) (PubMed:19915044). (Microbial infection) Acts as a receptor for Herpes simplex virus 1/HHV-1. (Microbial infection) Acts as a receptor for Herpes simplex virus 2/HHV-2.
CD270, HVEA, HVEM, UNQ329/PRO509, TNFRSF14, Tumor necrosis factor receptor superfamily member 14, Herpes virus entry mediator A, Tumor necrosis factor receptor-like 2, Herpesvirus entry mediator A, HveA, TR2
Rabbit Recombinant Monoclonal TNFRSF14/HVEM antibody. Suitable for ICC, IHC-P, WB and reacts with Human samples. Immunogen corresponding to Recombinant Fragment Protein within Human TNFRSF14 aa 1-200.
pH: 7.8 - 8.6
Preservative: 0.09% Sodium azide
Constituents: 98% Borate buffered saline
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Detection of human HVEM/TNFRSF14 in FFPE tonsil by IHC. Antibody: Rabbit anti-HVEM/TNFRSF14 recombinant monoclonal antibody [BLR062G] (A700-062). Secondary: HRP-conjugated goat anti-rabbit IgG. Substrate: DAB.
Detection of human HVEM/TNFRSF14 in FFPE lung carcinoma by IHC. Antibody: Rabbit anti-HVEM/TNFRSF14 recombinant monoclonal antibody [BLR062G] (A700-062). Secondary: HRP-conjugated goat anti-rabbit IgG. Substrate: DAB.
Detection of human HVEM/TNFRSF14 in FFPE SK-MEL-28 cells by ICC. Antibody: Rabbit anti-HVEM/TNFRSF14 recombinant monoclonal antibody [BLR062G] (A700-062). Secondary: HRP-conjugated goat anti-rabbit IgG. Substrate: DAB.
Samples: Whole cell lysate (50 µg) from SK-MEL-28, A2058, UACC-257, MDA-MB-435, and Malme-3M cells prepared using NETN lysis buffer. Antibody: Rabbit antiHVEM/TNFRSF14 recombinant monoclonal antibody [BLR062G] (A700-062) used at 1:1000. Secondary: HRP-conjugated goat anti-rabbit IgG. Chemiluminescence with an exposure time of 30 seconds.
All lanes: Western blot - Anti-HVEM/TNFRSF14 antibody [BLR062G] - BSA free (ab314104) at 1/1000 dilution
Lane 1: SK-MEL-28 Whole cell lysate at 50 µg
Lane 2: A2058 Whole cell lysate at 50 µg
Lane 3: UACC-257 Whole cell lysate at 50 µg
Lane 4: MDA-MB-435 Whole cell lysate at 50 µg
Lane 5: Malme-3M Whole cell lysate at 50 µg
All lanes: HRP-conjugated goat anti-rabbit IgG
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com